Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

NCT00544466 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: fludarabine phosphate
DRUG: melphalan
PROCEDURE: allogeneic hematopoietic stem cell transplantation
RADIATION: intensity-modulated radiation therapy

Sponsor

City of Hope Medical Center

Collaborators

[object Object]